INSPIRE MEDICAL SYSTEMS INVESTORS: Inspire Medical Systems, Inc. (INSP) has been Sued for Securities Fraud, Investors are Urged to Contact BFA Law

Core Viewpoint - Inspire Medical Systems, Inc. is facing a class action lawsuit for securities fraud following a significant drop in stock price due to alleged violations of federal securities laws [2][4]. Group 1: Lawsuit Details - The lawsuit has been filed against Inspire Medical Systems and certain senior executives, asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [4]. - Investors have until January 5, 2026, to request to lead the case, which is pending in the U.S. District Court for the District of Minnesota [4]. Group 2: Company Background - Inspire Medical Systems develops and manufactures an implantable medical device for treating sleep apnea, with the latest version being Inspire V, which received FDA approval on August 2, 2024 [5]. Group 3: Stock Performance and Issues - On August 4, 2025, Inspire disclosed that the launch of Inspire V would face an "elongated timeframe," leading to a reduction in 2025 earnings per share guidance by over 80% [8]. - The stock price dropped by $42.04 per share, or more than 32%, from $129.95 on August 4, 2025, to $87.91 on August 5, 2025, following this announcement [9]. Group 4: Allegations of Mismanagement - The lawsuit alleges that Inspire failed to adequately prepare clinicians and payors for the rollout of Inspire V, resulting in significant delays and weak demand due to excess inventory of older devices [7][8].